P968: ADDITION OF IXAZOMIB TO POMALIDOMIDE AND DEXAMETHASONE IMPROVES PROGRESSION-FREE SURVIVAL FOR MULTIPLE MYELOMA PATIENTS PROGRESSING ON LENALIDOMIDE AS PART OF 1ST LINE THERAPY: ALLIANCE A061202
HemaSphere | June 23, 2022 | Volume: 6 | Issue: No issue available | Pages: 858-859
10.1097/01.hs9.0000846740.75414.50